CYTOMX THERAPEUTICS INC. - COMMON STOCK

CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

04 мар 2024 05:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming March Investor Conferences

27 фев 2024 05:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

24 янв 2024 05:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference

12 янв 2024 05:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Outlines 2024 Company Priorities and Milestones

04 янв 2024 05:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

21 дек 2023 05:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

07 ноя 2023 13:15:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming November Investor Conferences

01 ноя 2023 05:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Report Third Quarter 2023 Financial Results on November 7, 2023

31 окт 2023 05:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b at the SITC 2023 Annual Meeting

30 окт 2023 05:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Presents Preclinical Profile of EpCAM-directed Antibody Drug Conjugate CX-2051 at 2023 World ADC Conference

18 окт 2023 13:30:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at Upcoming September Investor Conferences

05 сен 2023 13:05:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference

10 авг 2023 13:05:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

08 авг 2023 13:15:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Report Second Quarter 2023 Financial Results on August 8, 2023

01 авг 2023 05:00:02 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces New Employment Inducement Grants

20 июл 2023 06:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Appoints Yu-Waye (Wayne) Chu, M.D., as Chief Medical Officer

17 июл 2023 05:00:01 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Announces $30 Million Private Placement from BVF Partners L.P.

30 июн 2023 05:00:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics to Present at the Jefferies Healthcare Conference

01 июн 2023 13:05:00 Источник Nasdaq GlobeNewswire

CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

09 май 2023 13:15:00 Источник Nasdaq GlobeNewswire